Navigation Links
After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
Date:7/11/2013

EXTON, Pa., July 11, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, for late-phase products for chronic kidney disease (CKD) patients—including AbbVie's altrasentan, Concert Pharmaceuticals' CTP-499, Mitsubishi Tanabe's MP-146/AST-120, Fibrogen's FG3019, Pfizer's PF00487791 and PF04634817 and Eli Lilly's LY2382770—the percentage of likely candidates is typically, but not always highest, in Stage 3b and Stage 4. TreatmentTrends: Chronic Kidney Disease Stages 1-5 ND (US) also finds that, among physicians who treat CKD, familiarity with new products in development is low, but interest is generally high after reviewing brief product profiles.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO )

The report also finds that among 250 surveyed nephrologists, endocrinologists and primary care physicians (PCPs), PCPs are significantly more likely than other physician groups to make the initial diagnosis of CKD, and PCPs account for the majority (51 percent) of the CKD non-dialysis patient referrals that nephrologists receive. Physicians report that CKD patients are most often diagnosed in Stage 3; nephrologists report CKD patients are diagnosed significantly later in the disease process compared with what PCPs and endocrinologists report.

 "Eighty-six percent of physicians believe that the ideal timing for a new CKD agent designed to slow disease progression would be either during treatment of patients with early symptoms or for asymptomatic patients," said BioTrends Research Group Director Rob Dubman. "Given this, these patients are likely to be with the PCP or endocrinologist at that point during the dise
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
3. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
4. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
5. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
6. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
7. Masimo to Report Second Quarter 2012 Financial Results after Market Close on August 1
8. Onyx Pharmaceuticals To Report Second Quarter 2012 Financial Results After Market On August 1, 2012
9. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
10. Lance Armstrong Update: Arrogant Even After Conceding Doping Charges, Asserts Former White House & WADA Spokesman Robert Weiner; Victory for Clean Sport but "Dark Message" Is Science Must Catch Up to Masking Agents Allowing Cheating
11. Protection Against Whooping Cough Waned During the Five Years After Fifth Dose of DTaP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report describes ... veterinary medicine and pharmaceuticals as well as improvement ... important in the application of biotechnology to manage ...
(Date:8/4/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... and six months ended June 30, 2015 and updated ... its earnings conference call this morning, August 4, 2015, ... can join the call by dialing (855) 582-8078. The ... , Year-to-date net revenues of $38.3 million, an increase ...
(Date:8/3/2015)... 3, 2015  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... results for the fiscal third quarter 2015 after the ... The Company will also host a conference call ... a.m. Central Time (10:00 a.m. Eastern Time). Investors may ...
Breaking Medicine Technology:Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... , , GLEN BURNIE, Md., Dec. 1 ... for home testing and evaluation of sleep-disordered breathing, today announced ... officer. Hassett was most recently president of Matria Healthcare, ... into a $350 million industry leader in total population health, ...
... 1 Exagen Diagnostics, Inc., a molecular diagnostics laboratory ... announced the appointment of Scott Glenn as chairman of ... , Prior to joining Exagen, Glenn was managing partner ... of successful biomedical companies including Prometheus Laboratories, Santarus, Dexcom, ...
Cached Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2
(Date:8/4/2015)... , ... August 04, 2015 , ... ... contemporary look at unique artistic expressions from a diverse group of exceptionally talented ... Is Beautiful Music & Art Festival on September 25-27, 2015 in Downtown Las ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... of a new product suite designed to provide pharmaceutical and healthcare organizations with ... on multi-sourced and cross-referenced data from regulatory filings (including the FDA and HealthCanada), ...
(Date:8/4/2015)... ... August 04, 2015 , ... METTLER TOLEDO ... Seminar featuring researchers from Lubrizol, Pfizer, and Merck. This free online ... Process development project timelines often require informed decisions with limited process understanding. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Oriental Trading Company, Inc., the ... and school supplies, has developed engaging and affordable teacher supplies based on the ... student rewards, classroom decorations, crafts and educational resources featuring Carleā€™s vibrant illustrations and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rock Your Hair, http://www.rockyourhair.com ... Bash Tour. In addition, they have signed Lexi Noel, dubbed the Teen Beauty Queen ... print and overall branding opportunities for the company. , The Pop & Rock ...
Breaking Medicine News(10 mins):Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 3Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2
... memory, language, and other cognitive skills after bypass surgery. ... or the pump used to replace heart function during ... The findings may lead to better approaches to prevent ... receive. , The study, published in the May Annals ...
... Murad, Inc. announced today,the appointment of Fernando ... Business for Latin America. In this position, Braga ... presence in key,areas, identify prospective partners and create ... http://www.newscom.com/cgi-bin/prnh/20080519/LAM066 ), "Fernando joins the Murad ...
... Diego, California, May 19, 2008 NPS Pharmaceuticals, Inc. ... data at the annual Digestive Disease Week (DDW) Congress ... reduce dependence upon parenteral nutrition (PN) in patients with ... , The Phase 3 study evaluated two ...
... ARLINGTON HEIGHTS, Ill., May 19 Plastic,surgeons performed ... ranging from repairing dog bite wounds and birth ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080519/DC22812 ), Who ... has reconstructive,surgery changed their lives?, On average, ...
... The Epilepsy,Foundation today released important information about epilepsy and ... recent news about,Senator Edward Kennedy (D-Mass)., Senator Kennedy, ... S.,Senate, reportedly experienced a seizure on Saturday. A seizure ... One in ten Americans,will have a single seizure at ...
... smoke, chemicals boosts odds, but routine screening could ... may be at increased risk for bladder cancer and ... of California, San Francisco, researchers. , The team tested ... age was 45, and found that 93 tested ...
Cached Medicine News:Health News:Bypass not to blame for heart patients' mental decline 2Health News:Murad, Inc., Appoints Fernando Braga, Jr. as Director of International Business for Latin America 2Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 2Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 3Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 4Health News:Each Day, Plastic Surgeons Are Reconstructing Lives: Restoring Function, Improving Appearances, and Elevating Self-Esteem 2Health News:The Epilepsy Foundation Sheds Light on Seizures 2Health News:Firefighters May Face Higher Risk of Bladder Cancer 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: